![René Vleugels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. René Vleugels is a Chief Executive Officer at CyTuVax BV and a Co-Founder at NovoVacs BV.
Dr. Vleugels was previously employed as a Founder by AdjuTec BV, a Managing Director by MUbio Holding BV, and a Principal by Maastricht University.
He received his doctorate degree from Radboud University Nijmegen.
Postes actifs de René Vleugels
| Sociétés | Poste | Début |
|---|---|---|
NovoVacs BV | Fondateur | 01/09/2009 |
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology Develops vaccinations for cancer treatment | Directeur Général | 01/01/2011 |
Anciens postes connus de René Vleugels
| Sociétés | Poste | Fin |
|---|---|---|
Maastricht University
 Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AdjuTec BV
 AdjuTec BV Pharmaceuticals: MajorHealth Technology Manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients | Fondateur | - |
MUbio Holding BV
 MUbio Holding BV BiotechnologyHealth Technology Develops and manufactures antibody reagents for cell biology and biomedical research including cancer and stem cell research | Fondateur | - |
Formation de René Vleugels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Maastricht University
Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MUbio Holding BV
MUbio Holding BV BiotechnologyHealth Technology Develops and manufactures antibody reagents for cell biology and biomedical research including cancer and stem cell research | Health Technology |
NovoVacs BV | |
CyTuVax BV
CyTuVax BV Pharmaceuticals: MajorHealth Technology Develops vaccinations for cancer treatment | Health Technology |
AdjuTec BV
AdjuTec BV Pharmaceuticals: MajorHealth Technology Manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients | Health Technology |
